Ratings EQS Group AG

Equities

EQS

DE0005494165

Market Closed - Xetra 11:36:03 2024-04-10 am EDT 5-day change 1st Jan Change
39.8 EUR -0.75% Intraday chart for EQS Group AG 0.00% -0.75%

Summary

  • From a short-term investment perspective, the company presents a deteriorated fundamental configuration.

Strengths

  • According to sales estimates from analysts polled by Standard & Poor's, the company is among the best with regard to growth.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • Analyst opinion has improved significantly over the past four months.
  • The divergence of price targets given by the various analysts who make up the consensus is relatively low, suggesting a consensus method of evaluating the company and its prospects.

Weaknesses

  • The group shows a rather high level of debt in proportion to its EBITDA.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • For the last four months, earnings estimated by analysts have been revised downwards with respect to the next two years.
  • The appreciation potential seems limited due to the average target prices set by the analysts covering the stock.
  • The average price target of analysts who are interested in the stock has been significantly revised downwards over the last four months.
  • Over the past twelve months, analysts' consensus has been significantly revised downwards.
  • Sales estimates for the next fiscal years vary from one analyst to another. This clearly highlights a lack of visibility into the company's future activity.
  • The company's earnings releases usually do not meet expectations.

Ratings chart - Surperformance

Sector: Software

1st Jan change Capi. Investor Rating ESG Refinitiv
-0.75% 426M -
+8.78% 3,028B
C+
+2.45% 80.47B
B
+1.94% 76.81B
B+
-11.97% 54.2B
B+
-16.33% 51.74B
B-
+25.74% 47.88B
D+
+16.44% 39.62B
D+
+56.22% 35.14B
D+
-11.26% 24.18B
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
-
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
Divergence of analysts' opinions
-
Divergence of Target Price
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes